The generation of transgenic animals using a promoter to direct the expression of a gene of interest is a continuously developing technique. Traditionally, a short fragment from the promoter of a gene with the desired expression profile (plasmid-based transgene) has been used as a vector to express a gene of interest. However, more recently, large pieces of DNA such as yeast artificial chromosomes (YACs), bacterial artificial chromosomes (BACs), and P1-based artificial chromosomes (PACs) are replacing plasmid-based transgenes, which is due mainly to three reasons: ( i ) large pieces of DNA are more likely to contain all of the promoter elements needed for faithful gene expression; ( ii ) expression of the gene of interest is more likely to be copy number dependent; and ( iii ) there is less variability in the pattern of expression across transgenic lines (2, 3) . Recently, the modification of BACs and PACs has become a routine technique (5, 6) . Usually, the gene of interest is placed downstream of the ATG of a chosen gene in the BAC or PAC. The rationale for using BACs and PACs is that these large fragments of DNA are likely to contain all or most of the cis elements that regulate the expression of the gene chosen to drive the expression of the transgene. Therefore, it is of obvious importance to know the localization of the gene chosen for expression within the BAC or PAC, as a localization too proximal to one of the ends can result in a loss of some regulatory elements upstream or downstream of the ATG needed to drive faithful gene expression. This orientation can be achieved by restriction analysis, which is usually difficult and cumbersome.
Here, we present a straightforward method that allows simultaneous modification of a BAC or PAC and the localization of the gene within the BAC or PAC in a single step.
For this purpose, we generated an expression cassette containing the following features: the gene to be expressed (here the iCre recombinase), a codonimproved Cre recombinase (4) with a polyadenylation signal from bovine growth hormone (BD Biosciences Clontech, Palo Alto, CA, USA) and an ampicillin resistance cassette flanked by two Flp recombinase target (FRT) sites and containing an internal Not I restriction site to allow the localization of the gene within the PAC or BAC (Figure 1) .
A 120-kb PAC containing the Kainic receptor 1 gene (KA 1 ) was isolated for use as a vector to drive the expression of the iCre recombinase. The KA 1 PAC was modified by ET-recombination (homologous recombination in E. coli ) as previously described (6) . Briefly, a 150-bp homology arm to the KA 1 gene was amplified by PCR and cloned in front of the iCre recombinase, replacing the internal ATG of the KA 1 receptor gene with the iCre ATG. A 3 ′ homology region to the KA 1 gene of 150 bp was amplified by PCR and cloned at the end of the construct (Figure 1) . DH10B bacteria containing the KA 1 PAC were transformed with a tetracycline-resistant version of the plasmid pBAD ET γ [plasmid that contains the necessary elements to carry out homologous recombination and modification of the PAC (6)]. The cells were induced with arabinose (0.2%), and competent cells were generated. The digested targeting vector was electroporated into competent cells previously induced with arabinose and containing the KA 1 PAC. Putative positive colonies believed to have undergone homologous recombination were selected in the presence of kanamycin (PAC vector resistance) and ampicillin. Homologous recombination of the targeting construct with the appropriate sequences in the PAC was confirmed by restriction analyses, Southern analyses, and PAC sequencing. The frequency of correct targeted PACs was 8 of 10 (i.e., 8 of 10 colonies that had undergone recombination had the iCre cassette inserted in the right place).
The localization of the KA 1 gene within the PAC was performed as follows. The modified PAC KA 1 was subjected to Not I digestion and analyzed by pulsed-field gel electrophoresis (Figures 1 and 2) . The size-separated DNA was transferred to nylon membrane and probed with a radiolabeled oligonucleotide immediately upstream Benchmarks Figure 1 . Schematic representation of the modification of the KA 1 PAC. Shown is an expression cassette containing the iCre, a growth hormone polyadenylation signal, and an ampicillin resistance cassette flanked by two FRT sites and containing an internal Not I recognition site. The cassette was recombined into the KA 1 PAC, and the location of the KA 1 gene within the PAC was determined by a Not I digestion. The probes used to identify the 5 ′ and 3 ′ regions from the endogenous KA 1 ATG are denoted 5 ′ probe and 3 ′ probe, respectively. The ampicillin cassette and internal Not I site are removed upon electroporation of the modified PAC DNA into MM294 Flp-expressing bacteria.
of the ATG of the KA 1 gene (5 ′ probe), which detected a fragment of 90 kb. Following stripping, the membrane was hybridized with a 3 ′ probe (immediately downstream of the ATG of the KA 1 gene), which detected a 40-kb fragment. From these analyses, we estimated that the KA 1 gene was contained within the last third of the PAC with a 90-kb 5 ′ and a 40-kb 3 ′ sequence. A third fragment of 17 kb was present in the pulsed-field electrophoresis gel and corresponded to the backbone of the PAC vector following Not I digestion.
Following homologous recombination of the targeting vector in bacteria, the ampicillin cassette is no longer necessary and could interfere with the expression of the desired gene. Therefore, it is preferable to remove it. Based on this fact, the Not I site was placed between the FRT sites flanking the ampicillin cassette, allowing its removal upon treatment with Flp recombinase. The removal of the internal Not I site in this way has the added advantage that the modified PAC insert can again be excised intact from its vector backbone using a Not I digestion for subsequent oocyte injection. The modified KA 1 PAC was electroporated in MM294 Flp-expressing bacteria (1) to remove the ampicillin cassette and the internal Not I site (Figures 1 and 2) .
The use of large pieces of DNA such as BACs and PACs to drive expression of a transgene is becoming increasingly popular because of techniques that allow easy manipulation of the DNA and because the resulting transgene usually directs faithful expression. However, to take full advantage of BACs and PACs as expression vectors, the localization of the chosen gene within the BAC or PAC is required. Here, we present a strategy that allows the straightforward localization of a desired gene within a BAC or PAC in a simple and straightforward way. The whole process comprises ( i ) PCR amplification and cloning of the homology arms flanking the iCre cassette, ( ii ) modification of the BAC/PAC using ET-cloning, ( iii ) orientation of the BAC/PAC combining a Not I digestion and Southern analysis using 5 ′ upspream and 3 ′ donwnstream probes, and ( iv ) removal of the ampicillin cassette flanked by two FRT sites. The combination of the modification of a BAC or PAC by ET-recombination (6) and the simultaneous introduction of a Not I recognition site (removed together with the prokaryotic selection cassette before oocyte injection of the transgene) will simplify the localization of a desired gene within a BAC or PAC in one unique step.
The simplicity of this method should allow fast and easy orientation of a gene into a PAC or PAC in comparison with the traditional time-and effort-demanding methods such as restriction analyses. To our knowledge, this is the first report in which, by a simple addition of a Not I site in the targeting construct used to modify a BAC or PAC, the position of a gene into a BAC or PAC can be easily determined. Approximately 100 cells were microdissected from human tonsil and used for RT-PCR. GAPDH-specific primers were used to amplify for 25, 45, or 65 cycles. The GAPDH product (476 bp) was the only band present at all conditions.
